• Founded: 2014
  • Location: Dallas, TX
  • Employee range: 50 - 200
  • Clinical stage: Clin3
  • Therapy area: COVID-19
  • Drug types: NEU, VAC, INF, CVV
  • Lead product: UB-612
  • Product link:
  • Funding: $85M IPO Nov 2021

job board

Short description:

Endobody Vaccines, Synthetic Peptides Vaccine

Drug notes:

UB-311 Clin2 Alzheimer's; UB-312 Clin1 Parkinson's, DLB, MSA; UB-313 Clin1 migraine; VXX-401 Clin1 hypercholesterolemia; undisclosed RD/Clin0 Alzheimer's, undisclosed

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy